At Arbor Research, we strive at every level to maintain a process of investigation that is transparent and ethical, one that benefits from the rigors of peer review. And while inquiry itself is rewarding, we pursue our many projects with one overarching goal in mind: making life better for patients worldwide challenged with serious, chronic health issues such as chronic kidney disease and end-stage organ disease. To help them, we have become expert practitioners of outcomes research, knowing how to ask insightful questions to achieve useful, evidence-based answers.
Arbor Research investigators and staff collaborate together and with other scientists to design robust protocols to answer important clinical questions. Some studies are observational, and analysis of the data often helps inform future clinical practice and patient decisions. Interventional clinical trials examine the safety and effectiveness of a drug or treatment on a patient population. Analysis of the data helps determine if a drug or a treatment has a benefit for a group of patients. Many studies now focus on patients’ experience with complex illnesses and treatments. All clinical studies must be carefully designed and monitored closely to protect participant health and safety. Data are analyzed meticulously and the results reported clearly to the medical and patient communities. Our diverse staff of clinical research professionals participates in all aspects of study design and conduct, from concept development through to publication of results.